Related Experiment Videos
Treatment options of AIDS-related lymphoma
Ingo G H Schmidt-Wolf1, Jürgen K Rockstroh, Uwe Schlegel
1Medizinische Universitätsklinik und Poliklinik I, Sigmund-Freud-Str 25, 53105 Bonn, Germany. picasso@uni-bonn.de
Expert Opinion on Pharmacotherapy
|July 25, 2003
Abstract:
Recently, the median survival of patients with AIDS-related lymphoma has changed significantly. This effect is mainly because of changes in the use of antiviral (highly active antiretroviral therapy; HAART) or chemotherapy regimens. Several novel treatment options have been explored in patients with lymphoma. It is hoped that innovative strategies will lead to a survival benefit in these patients. In this review, we present an update of current strategies for the treatment of AIDS-related lymphoma.